Skip to main content
Giuseppe Delpriore, MD, Obstetrics & Gynecology, New York, NY

GiuseppeDelprioreMD

Obstetrics & Gynecology New York, NY

Gynecologic Oncology

Physician

Dr. Delpriore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Delpriore's full profile

Already have an account?

  • Office

    268 Canal St
    New York, NY 10013
    Phone+1 212-966-0228
    Fax+1 212-966-9330

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1987 - 1991
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1987
  • University of Rochester
    University of RochesterFellowship, Gynecologic Oncology

Certifications & Licensure

  • HI State Medical License
    HI State Medical License 2000 - 2026
  • IL State Medical License
    IL State Medical License 1987 - 2026
  • GA State Medical License
    GA State Medical License 2013 - 2025
  • IN State Medical License
    IN State Medical License 2010 - 2025
  • NY State Medical License
    NY State Medical License 1989 - 2025
  • OK State Medical License
    OK State Medical License 2014 - 2016
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Publications & Presentations

PubMed

Press Mentions

  • Bria-IMT plus Immunotherapy Shows Early Promise in Breast Cancer Brain Metastasis
    Bria-IMT plus Immunotherapy Shows Early Promise in Breast Cancer Brain MetastasisOctober 24th, 2024
  • Briacell Reports Positive Overall Survival (Os) in Metastatic Breast Cancer
    Briacell Reports Positive Overall Survival (Os) in Metastatic Breast CancerSeptember 11th, 2024
  • Outcomes with CDK4/6 Inhibitors Vary in BC
    Outcomes with CDK4/6 Inhibitors Vary in BCJuly 30th, 2024
  • Join now to see all